Michael France

2.2k total citations
42 papers, 1.5k citations indexed

About

Michael France is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michael France has authored 42 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 20 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michael France's work include Lipoproteins and Cardiovascular Health (14 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers) and Cancer, Lipids, and Metabolism (5 papers). Michael France is often cited by papers focused on Lipoproteins and Cardiovascular Health (14 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers) and Cancer, Lipids, and Metabolism (5 papers). Michael France collaborates with scholars based in United Kingdom, United States and Australia. Michael France's co-authors include Barbara J. Boucher, John Barragry, R D Cohen, Handrean Soran, Kennedy Cruickshank, Richard Body, Simon Carley, Allan S. Jaffe, Kevin Mackway‐Jones and Garry McDowell and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Michael France

42 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael France United Kingdom 19 640 435 297 223 215 42 1.5k
Alon Schaffer Italy 25 537 0.8× 950 2.2× 210 0.7× 287 1.3× 57 0.3× 80 1.8k
Monica Verdoia Italy 27 1.0k 1.6× 1.7k 3.9× 271 0.9× 416 1.9× 95 0.4× 190 3.0k
Efstathios D. Pagourelias Greece 21 458 0.7× 969 2.2× 355 1.2× 67 0.3× 50 0.2× 80 1.8k
Bent Lind Denmark 21 182 0.3× 600 1.4× 238 0.8× 56 0.3× 165 0.8× 78 1.8k
Christian M. Madsen Denmark 25 1.5k 2.4× 695 1.6× 842 2.8× 112 0.5× 164 0.8× 50 2.3k
J P Boissel France 17 480 0.8× 717 1.6× 295 1.0× 416 1.9× 67 0.3× 43 2.1k
Matteo Nardin Italy 21 283 0.4× 583 1.3× 103 0.3× 131 0.6× 47 0.2× 106 1.1k
James Ehrlich United States 17 324 0.5× 552 1.3× 489 1.6× 50 0.2× 63 0.3× 23 2.0k
Mhairi K. Sigrist Canada 19 389 0.6× 492 1.1× 126 0.4× 68 0.3× 90 0.4× 29 1.9k
Azmi Nabulsi United States 11 152 0.2× 210 0.5× 771 2.6× 288 1.3× 33 0.2× 18 1.8k

Countries citing papers authored by Michael France

Since Specialization
Citations

This map shows the geographic impact of Michael France's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael France with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael France more than expected).

Fields of papers citing papers by Michael France

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael France. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael France. The network helps show where Michael France may publish in the future.

Co-authorship network of co-authors of Michael France

This figure shows the co-authorship network connecting the top 25 collaborators of Michael France. A scholar is included among the top collaborators of Michael France based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael France. Michael France is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schofield, Jonathan, Michael France, Darren M. Ashcroft, et al.. (2024). Beyond LDL-C: unravelling the residual atherosclerotic cardiovascular disease risk landscape—focus on hypertriglyceridaemia. Frontiers in Cardiovascular Medicine. 11. 1389106–1389106. 10 indexed citations
2.
3.
Yadav, Rahul, Salam Hama, Yifen Liu, et al.. (2017). Effect of Roux-en-Y Bariatric Surgery on Lipoproteins, Insulin Resistance, and Systemic and Vascular Inflammation in Obesity and Diabetes. Frontiers in Immunology. 8. 1512–1512. 48 indexed citations
4.
Schofield, Jonathan, See Kwok, Michael France, et al.. (2016). Knowledge gaps in the management of familial hypercholesterolaemia. A UK based survey. Atherosclerosis. 252. 161–165. 17 indexed citations
5.
France, Michael. (2016). Homozygous familial hypercholesterolaemia: update on management. Paediatrics and International Child Health. 36(4). 243–247. 18 indexed citations
6.
France, Michael. (2014). The withdrawal of the thyromimetic eprotirome. Clinical Lipidology. 9(5). 483–486. 1 indexed citations
7.
Schofield, Jonathan, et al.. (2014). A review of paradoxical HDL-C responses to fenofibrate, illustrated by a case report. Journal of clinical lipidology. 8(4). 455–459. 7 indexed citations
8.
Yadav, Rahul, Michael France, Naveed Younis, et al.. (2012). Extended-release niacin with laropiprant: a review on efficacy, clinical effectiveness and safety. Expert Opinion on Pharmacotherapy. 13(9). 1345–1362. 21 indexed citations
9.
Soran, Handrean, Michael France, See Kwok, et al.. (2011). Apolipoprotein B100 is a better treatment target than calculated LDL and non-HDL cholesterol in statin-treated patients. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 48(6). 566–571. 15 indexed citations
10.
Body, Richard, Simon Carley, Garry McDowell, et al.. (2011). Rapid Exclusion of Acute Myocardial Infarction in Patients With Undetectable Troponin Using a High-Sensitivity Assay. Journal of the American College of Cardiology. 58(13). 1332–1339. 254 indexed citations
11.
Goonetilleke, Kolitha, et al.. (2007). Diagnostic and Prognostic Value of Plasma Tumor M2 Pyruvate Kinase in Periampullary Cancer. Pancreas. 34(3). 318–324. 29 indexed citations
12.
Virlos, Ioannis, et al.. (2005). Hyperlipidaemia and outcome in acute pancreatitis. International Journal of Clinical Practice. 60(2). 156–159. 63 indexed citations
13.
Cueto–Manzano, Alfonso M., Vivion Crowley, Michael France, et al.. (2003). Bone histopathology and densitometry comparison between cyclosporine a monotherapy and prednisolone plus azathioprine dual immunosuppression in renal transplant patients. Transplantation. 75(12). 2053–2058. 32 indexed citations
14.
Jamieson, Glyn G., Michael France, & David I. Watson. (2002). Results of laparoscopic antireflux operations in patients who have Barrett's esophagus. Chest Surgery Clinics of North America. 12(1). 149–155. 14 indexed citations
15.
Kumar, Sudhesh, et al.. (1993). Screening strategies in the detection of microalbuminuria in insulin‐dependent diabetic patients. Practical Diabetes International. 10(4). 142–144. 2 indexed citations
16.
France, Michael, et al.. (1986). Bone and Mineral Metabolism and Chronic Alcohol Abuse. QJM. 59(229). 497–511. 106 indexed citations
17.
Barragry, John, Richard Long, Michael France, et al.. (1979). Intestinal absorption of cholecalciferol in alcoholic liver disease and primary biliary cirrhosis.. Gut. 20(7). 559–564. 35 indexed citations
18.
Barragry, John, Michael France, Barbara J. Boucher, & R D Cohen. (1979). METABOLISM OF INTRAVENOUSLY ADMINISTERED CHOLECALCIFEROL IN MAN. Clinical Endocrinology. 11(5). 491–495. 11 indexed citations
19.
20.
Boucher, Barbara J., R D Cohen, Michael France, & A. Stuart Mason. (1975). PLASMA FREE FATTY ACID TURNOVER IN TOTAL LIPODYSTROPHY. Clinical Endocrinology. 4(1). 83–88. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alon Schaffer Breakdown of academic impact, for papers by Monica Verdoia Breakdown of academic impact, for papers by Efstathios D. Pagourelias Breakdown of academic impact, for papers by Bent Lind Breakdown of academic impact, for papers by Christian M. Madsen Breakdown of academic impact, for papers by J P Boissel Breakdown of academic impact, for papers by Matteo Nardin Breakdown of academic impact, for papers by James Ehrlich Breakdown of academic impact, for papers by Mhairi K. Sigrist Breakdown of academic impact, for papers by Azmi Nabulsi
Rankless by CCL
2026